Class / Patent application number | Description | Number of patent applications / Date published |
424752000 | Containing or obtained from Ginkgo (e.g., ginkgo biloba, maidenhair, etc.) | 35 |
20080226757 | Use of a Ginkgo Complexes for the Enhancement of Cognitive Functions and the Alleviation of Mental Fatigue - The invention is directed to the use of Ginkgo complexed with phosphatidylserine for the manufacture of a medicament or a dietary supplement for the enhancement of cognitive function and mental fatigue, i.e. to improve the factors related therewith such as to improve the speed of memory and memory quality, to increase accuracy and attention in activities in normal, healthy subjects, to prevent deterioration of the speed and quality of memory in people with decreased cognitive functions and to counteract cognitive fatigue, having also an influence on the mood, particularly in healthy children, young adults, middle-aged and/or old people. It is further provided the use of the Ginkgo phosphatidylserine complex for the treatment and prevention of a disease related with a decrease of the cognitive function and mental fatigue such as Dementia, e.g. Alzheimer's Disease. | 09-18-2008 |
20080254155 | Use of Ginkgo Biloba Extract in Preparation of a Composition for Lowering Cholesterol - The use of | 10-16-2008 |
20080286391 | Method for preparing ginkgo extracts having a low content of 4'-O-methyl pyridoxine and/or biflavones - The present invention relates to an improved multi-step method for preparing an extract from ginkgo biloba having a reduced content of 4′-O-methyl pyridoxine and/or biflavones, wherein the depletion is carried out by filtration over an adsorber resin and/or an ion exchanger and the substances to be removed are retained on the resin. The invention further relates to an extract from ginkgo biloba having a reduced content of 4′-O-methyl pyridoxine and/or biflavones, which is obtainable by the method according to the present invention, as well as to its use. | 11-20-2008 |
20090022825 | Method for Predicting Whether Subjects With Mild Cognitive Impairment (MCI) Will Develop Alzheimer's Disease - The invention provides methods of diagnosing mild cognitive impairment (MCI) in a patient and methods of predicting cognitive decline in patients who have MCI. The invention also provides methods for predicting if a patient who has MCI will develop Alzheimer's Disease (AD). | 01-22-2009 |
20090175968 | DIETARY COMPOSITIONS FOR PROMOTING BRAIN HEALTH - Dietary compositions are disclosed herein. For example, dietary compositions containing a combination of a phosphatidylserine, DHA, EPA, antioxidants, and | 07-09-2009 |
20090220624 | COMPOSITIONS COMPRISING APOCYNIN, GINKGO AND GINGER AND USES THEREOF - A composition comprising ginkgo biloba or extract or component thereof; apocynin; and a gingerol. The composition may be used to treat diseases such as CF and COPD. | 09-03-2009 |
20090232916 | FOOD PRODUCTS FOR DIABETICS - Disclosed is a novel food product characterized by a low glucose or glucose free content, a balanced functional fat content, and a proactive agent aimed for the diabetic and diabetic-prone populations. The food product of the invention is a functional food which may be used clinically to lower the lipid level in people suffering from an imbalanced lipid profile and which may progress towards diabetes complications and coronary vascular disorders. In particular embodiments the proactive agent can be any of a naturally occurring lipid, a synthetic or mimetic lipid which is not digestible by humans and interferes with body weight gain/loss, plant extracts and substances derived therefrom, antioxidants, animal-derived substances, minerals and pharmaceuticals, and any mixture thereof. | 09-17-2009 |
20090258095 | Use of a Ginkgo Biloba Extract for the Treatment of Mitochondrial Disease of Genetic Origin - The invention relates to the use of | 10-15-2009 |
20090274783 | HERBAL COMPOSITIONS AND METHODS FOR ENHANCING VITAL ENERGY AND ATHLETIC PERFORMANCE - Compositions, kits and methods are provided for enhancing vital energy and athletic performance, improving or restoring blood circulation, promoting mental acuity, reducing fatigue, and improving aerobic performance. In one embodiment, the composition comprises the herbal extracts of | 11-05-2009 |
20100015259 | Composition and method for improving human concentration, memory and other cognitive brain - This formulaic composition has synergistic effects on the mental function of humans including reduction of mental fatigue, maintenance and enhancement of concentration and mental vigor. The main components are theanine, at levels in excess of 200 mg/dose, and Gingko Biloba extract. Further additions include small amounts of Vitamins B | 01-21-2010 |
20100112104 | COSMETIC PREPARATIONS DESIGNED TO REDUCE UNSIGHTLY CELLULITE - The invention relates to a new derivative of aryldimethylpyrazolone of formula (I) which is effective in reducing unsightly cellulite, and compositions containing it. | 05-06-2010 |
20100151064 | THIAZOLHYDRAZIDES FOR TREATMENT OF NEURODEGENERATIVE DISEASES - Described are compounds having a thiazolhydrazide scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said thiazolhydrazide compounds can be used for prophylaxis and/or treatment of neurodegenerative diseases and conditions. | 06-17-2010 |
20100233304 | COMPOSITIONS COMPRISING UNSATURATED FATTY ACIDS AND NITRIC OXIDE RELEASING COMPOUNDS AND USE THEREOF FOR ENHANCING COGNITIVE AND RELATED FUNCTIONS - Compositions comprising one or more unsaturated fatty acids and one or more nitric oxide releasing compounds, and methods for using such compositions for enhancing cognitive function, reducing or preventing a decline of social interaction, reducing or preventing age-related behavioral changes, increasing trainability, maintaining optimal brain function, facilitating learning and memory, reducing memory loss, retarding brain aging, preventing or treating strokes, and preventing or treating dementia in an animal. Preferably, the compositions are food compositions useful for enhancing cognitive function in humans and companion animals. | 09-16-2010 |
20100247688 | PIRENZEPINE AND DERIVATIVES THEREOF AS ANTI-AMYLOID AGENTS - The present invention relates to a compound that is capable of inhibiting the formation of β-amyloid plaques, of reducing and/or retarding the increase the β-amyloid plaque load in the brain of an animal, particularly a mammal, but especially a human. In particular, the invention relates to compounds of formula (I) and to metabolites thereof. | 09-30-2010 |
20110086118 | COMPOSITION FOR PREVENTION OF INFLUENZA VIRAL INFECTION COMPRISING SUMAC EXTRACT, AIR FILTER COMPRISING THE SAME AND AIR CLEANING DEVICE COMPRISING THE FILTER - Disclosed are a composition for the prophylaxis of influenza viral infection comprising a sumac extract, an air filter coated with the same, and an air cleaner comprising the air filter. Having high inhibitory activity against influenza virus, the composition comprising a sumac extract can be applied to the prevention of influenza viral infection. Also, the filter coated with the composition can remove influenza viruses from the air so that it can be employed in an air cleaner for the prophylaxis of influenza viral infection. | 04-14-2011 |
20110086119 | Preparation for the relief of disease - A composition including (a) a Platelet Activating Factor (PAF) Inhibitor and (b) an antioxidant which interferes with the arachidonic acid cascade and also has antioxidant activity. The composition is useful for the treatment or the relief of inflammatory diseases, thrombosis, cardiac problems, and/or conditions caused by platelet induced blood clotting. | 04-14-2011 |
20110091585 | HERBAL COMPOSITIONS AND METHODS FOR ENHANCING VITAL ENERGY AND ATHLETIC PERFORMANCE - Compositions, kits and methods are provided for enhancing vital energy and athletic performance, improving or restoring blood circulation, promoting mental acuity, reducing fatigue, and improving aerobic performance. In one embodiment, the composition comprises the herbal extracts of | 04-21-2011 |
20110159123 | Composition For Relieving Premenstrual Syndrome - A composition is provided for relieving premenstrual syndrome. The composition comprises about 5% to about 95% by weight of a tribulus terrestris extract and about 5% to about 95% by weight of one or more herbal extracts selected from organic white willow extract, Red raspberry leaf extract, Chaste tree berry extract, Cramp bark extract, and Gingko biloba extract. The composition further comprises dehydroepiandrosterone, amino acids, vitamins and derivatives thereof, minerals and derivatives thereof, carbohydrates, citric acid, natural flavors, stevia, juice powder, maltodextrin, and silicon dioxide. The vitamins and derivatives thereof comprise, for example, vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B12, vitamin B9, vitamin B7, vitamin C, vitamin D3, and d-calcium pantothenate. The minerals comprise, for example, calcium, magnesium, manganese, sodium, and potassium. The ingredients are mixed in a liquid carrier and administered as a hot or cold beverage. | 06-30-2011 |
20110189318 | METHODS FOR ENHANCING THE EXPRESSION OF INTRACELLULAR REDOX-ASSOCIATED FACTORS - The present invention provides methods for enhancing expression of a redox-associated factor, wherein kaempferol, quercetin or glycosides thereof, or any combination thereof is used as an active ingredient, and methods for enhancing expression of a redox-associated factor wherein ginkgo leaf extract, | 08-04-2011 |
20110250300 | COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATING TO OXIDATIVE STRESS - The present invention features methods for treating or preventing conditions, diseases, or disorders related to oxidative stress. In one embodiment, the method increases Nrf2 biological activity or expression. In particular, the invention provides for the treatment or prevention of diseases relating to oxidative stress including emphysema, sepsis, septic shock, ischemic injury, cerebral ischemia and neurodegenerative disorders, meningitis, encephalitis, hemorrhage, cerebral ischemia, heart ischemia, cognitive deficits and neurodegenerative disorders. | 10-13-2011 |
20110305781 | Use of Eclipta Prostrata and Other PPAR-GAMMA Inhibitors in Cosmetics and Compositions Thereof - The present invention describes compositions and methods for improving the appearance of skin, particularly, treating, ameliorating, preventing, delaying, and/or improving one or more signs of excess accumulation and/or production of subcutaneous fat, such as cellulite, and conditions related thereto, by topically applying compositions comprising | 12-15-2011 |
20120100232 | PROCESS FOR REMOVING PESTICIDES FROM GINKGO BILOBA EXTRACTS, AND EXTRACTS OBTAINABLE BY SAID PROCESS - Process for removing pesticides from | 04-26-2012 |
20120148689 | FILM COMPRISING ACTIVE DRUGS - The present invention is related to the composition and methods of manufacture of orally-dissolvable, edible films as a vehicle for the non-invasive administration of active drugs through the mucosal tissues of the oral cavity. The films include a water soluble film-forming polymer such as pullulan. Methods for producing the films are also disclosed. | 06-14-2012 |
20120301559 | DIETARY REGIMENS USEFUL FOR MIMICKING CALORIC RESTRICTIONS - The invention provides dietary regimens useful mimicking caloric restriction in animals. The regimens use a first diet containing one or more dietary supplements suitable for mimicking caloric restriction when the animal is a young animal; a second diet containing one or more dietary supplements suitable for mimicking caloric restriction when the animal is an adult animal; and a third diet containing one or more dietary supplements suitable for mimicking caloric restriction when the animal is a senior animal; wherein the dietary supplements in the first diet, second diet, and third diet are not all be the same dietary supplements. | 11-29-2012 |
20120301560 | COMPOSITIONS COMPRISING ANDROGRAPHIS PANICULATA EXTRACTS COMBINED WITH GINKGO BILOBA EXTRACTS COMPLEXED WITH PHOSPHOLIPIDS, AND THEIR USE - The present invention relates to compositions comprising | 11-29-2012 |
20130115319 | Herbal composition for lowering likelihood of stroke and methods for healing stroke patients - Compositions and methods are provided for lowering blood pressure, lowering blood sugar, lowering cholesterol, prevent stroke, removing age spots, curing stroke, or enlarging blood vessels to remove the toxins from the blood. In one embodiment, the composition comprises the herbal extracts of liquorice root, self-heal, mulberry leaves, chrysanthemum, ginkgo nuts, mangosteen, maltose and dextrin. The composition is used as a nutraceutical treatment to lower likelihood of stroke. | 05-09-2013 |
20130189382 | Use of fucoxanthin in the preparation of product for improving memory and having neuroprotective effect associated with neurodegenerative disorder - Use of fucoxanthin in the preparation of a product having neuroprotective effect associated with neurodegenerative disorder and improving memory is disclosed in the disclosure. A product having neuroprotective effect associated with neurodegenerative disorder is also disclosed in the disclosure. Fucoxanthin can inhibit oxidative stress of cells and has the effect of preventing or treating Alzheimer's disease and improving memory. | 07-25-2013 |
20130337093 | COMPOSITION COMPRISING NATURAL EXTRACTS - The invention relates to a method for providing an awaking effect and specifically affecting post lunch dip in a subject comprising providing a subject with a composition comprising an isolate of guarana plant, and at least one of (i) isolate of | 12-19-2013 |
20140057007 | Food, particularly a beverage for human consumption - Food, particularly a beverage for human consumption, the ingestion of which enhances cognitive processes such as intelligence, memory, creativity and mood, and/or produces energizing effects. Such food is composed of a composition dilutable or diluted in a liquid or semi-liquid solution. The composition includes at least one nootropic substance, preferably a cholinergic nootropic substance, that is, a substance involved in the formation and/or functioning of the acetylcholine neurotransmitter in combination with L-theanine | 02-27-2014 |
20140271953 | Use of Melicope Extracts to Improve Conditions Caused by Excess Lipids - Methods of using extracts of | 09-18-2014 |
20150044311 | METHOD FOR EXTRACTING AND SEPARATING GINKGOLIDES - A method for extracting and separating ginkgolides. The ginkgolides obtained through steps of extraction on a ginkgo leaf, further extraction, column chromatography, crystallization, and crystal mixing comprise 25.0% to 50.0% of bilobalide (C | 02-12-2015 |
20150050367 | TIMOSAPONIN COMPOUNDS - Provided herein are timosaponin compounds of Formula I, II, III, I′, II′ and III′, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are uses of said timosaponin compounds for preparing medicament for the treatment of diseases associated with beta-amyloid in hosts or subjects in need thereof. | 02-19-2015 |
20150320818 | METHOD FOR IMPROVING MEMORY OF A SUBJECT USING A COMPOSITION COMPRISING CISTANCHE AND GINKGO EXTRACTS - A method and composition useful for improving memory of a subject are disclosed. The method comprises the step of administering the composition to the subject. The composition consists essentially of | 11-12-2015 |
20160000674 | TOPICAL COMPOSITIONS FOR REDUCING THE EFFECTS OF AGING - The present invention comprises ternary compositions of tamibarotene and/or ammonium lactate in Pemulen for treatment of effects of aging. | 01-07-2016 |
20160038550 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH MEMORY LOSS - Methods and compositions are described for treating, preventing, ameliorating, or the like one or more symptoms associated with memory loss. Also described are pharmaceutical compositions including one or more of a monoamine oxidase inhibitor, a cyclooxygenase inhibitor, a nootropic agent, a terpene, a terpenoid, and a pharmaceutically acceptable carrier. | 02-11-2016 |